Filing Flows › Fate Therapeutics (FATE) › How it makes money
How Fate Therapeutics (FATE) makes money
Fate Therapeutics (FATE) made $2.1M of revenue in the second quarter 2026 (Q2 2026), +9% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $2.1M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $2.1M | +9% |
| Q1 2026 | $1.3M | -20% |
| Q4 2025 | $1.4M | -26% |
| Q3 2025 | $1.7M | -43% |
| Q2 2025 | $1.9M | -72% |
| Q1 2025 | $1.6M | -15% |
| Q4 2024 | $1.9M | +11% |
From Fate Therapeutics' 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Fate Therapeutics make money?
Fate Therapeutics (FATE) made $2.1M of revenue in the second quarter 2026 (Q2 2026), +9% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.